Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-06-08

Clinical Trial Update: Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating carvedilol versus placebo for treating post-traumatic stress disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARVEDILOL (Carvedilol)

Snippet

Sponsor: Columbia Northwest Pharmaceuticals | Conditions: Post-Traumatic Stress Disorder | Phase 2 | Status: UNKNOWN